Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Vaccination

Boots in talks with NHS England on COVID-19 vaccination programme

Exclusive: The UK’s largest pharmacy chain is working with NHS England to determine how its involvement in the COVID-19 vaccination effort will work.

Open access article

The Royal Pharmaceutical Society has made this article free to access in order to help healthcare professionals stay informed about an issue of national importance.

To learn more about coronavirus, please visit: https://www.rpharms.com/resources/pharmacy-guides/wuhan-novel-coronavirus

Boots logo

Source: Shutterstock.com

Boots has “significant experience and expertise in delivering vaccination programmes”, said a spokesperson for the multiple

Pharmacy multiple Boots is “in conversations” with NHS England about how it can help provide COVID-19 vaccines to patients, it has said.

In a statement to The Pharmaceutical Journal, a spokesperson for the multiple said it was “ideally placed to support the government COVID-19 vaccination programme”.

Initial details of the programme were announced on 9 November 2020 in a letter to GPs, requesting that primary care networks (PCNs) designate one site each from which a COVID-19 vaccine could be delivered.

An NHS England official later said in a webinar on 18 November 2020 for community pharmacy staff and GPs that there were “a number of different ways” for pharmacists to get involved in the delivery programme, through “mass vaccination sites or trust sites, or the PCN sites”.

But only a “small number of community pharmacies” would be commissioned as vaccination sites through a local enhanced service.

A slide accompanying the webinar advised community pharmacy contractors who want to help with the vaccination programme to contact their local PCN or regional NHS England pharmacy contracts team.

However, larger community pharmacy providers were advised to contact NHS England’s central pharmacy team.

The spokesperson for Boots said the multiple has “significant experience and expertise in delivering vaccination programmes and activating our extensive pharmacy and colleague network to support public health initiatives”.

“We continue to work closely and are in conversations with NHS England to understand the role that Boots can take in supporting this programme.”

In March 2020, Boots began supporting the government’s roll-out of testing facilities across the UK, and the company estimates that Boots staff have conducted nearly 1.5 million COVID-19 tests to date.

A spokesperson for LloydsPharmacy told The Pharmaceutical Journal that it was also “considering offering a COVID-19 vaccination service, as part of the NHS programme”.

However, they said the multiple “requires further details of requirements before we can ascertain which pharmacies would be viable to deliver at scale”.

“We would be very pleased to support a programme that allowed our most vulnerable to access the vaccine in a local and trusted environment, and have a number of skilled colleagues ready to embark on this historic vaccination programme,” they continued.

“We need to understand whether this will be in the form of supporting a mass vaccination centre, local GPs, or indeed through our own programme of pharmacies or potentially other models of delivery.”

Speaking at the webinar, Jill Loader, deputy director of pharmacy commissioning at NHS England and NHS Improvement, said community pharmacies could be called on to fill in gaps where provision from PCN sites is insufficient.

“Down the line, we expect there to be other vaccines available … We might well look at changing the model as the vaccination characteristics change, so this isn’t the model for ever,” she added.

“This is trying to anticipate the initial vaccines that we might have into the supply chain and we’ll continually be reviewing that.”

The Pharmaceutical Journal has approached NHS England for further comment.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20208568

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.